Therefore, it is likely that the reduced expression of PP2A regulatory subunits, in particular Ppp2r3a, may account for the impaired PP2A activity observed by the previous study in PASMCs from patients with pulmonary arterial hypertension [49]. Here, PPP2R3A is linked to pulmonary arterial hypertension.